CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, C. E.
Right arrow Articles by Day, N. P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, C. E.
Right arrow Articles by Day, N. P. J.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, November 2004, p. 1194-1197, Vol. 11, No. 6
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.6.1194-1197.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Lack of Association between Toll-Like Receptor 2 Polymorphisms and Susceptibility to Severe Disease Caused by Staphylococcus aureus

Catrin E. Moore,1* Shelley Segal,1 Anthony R. Berendt,2 Adrian V. S. Hill,1 and Nicholas P. J. Day1,3

Nuffield Department of Clinical Medicine, John Radcliffe Hospital,1 Bone Infection Unit, Nuffield Orthopaedic Centre NHS Trust, Oxford, United Kingdom,2 Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand3

Received 3 June 2004/ Returned for modification 12 August 2004/ Accepted 27 August 2004

To investigate a putative link between genetically determined variations in Toll-like receptor 2 (TLR2) and the occurrence of severe Staphylococcus aureus infection, the functional Arg753Gln single-nucleotide polymorphism and the GT repeat microsatellite in the TLR2 gene were examined in a large case-control study. No associations with disease or mortality attributable to these features were found.

* Corresponding author. Mailing address: Paediatric Infection and Immunity Laboratory, Department of Paediatrics, University of Oxford, Level 4, John Radcliffe Hospital, Oxford, OX3 9DU United Kingdom. Phone: 44 1865 221073. Fax: 44 1865 220479. E-mail: catrin.moore{at}paediatrics.ox.ac.uk.

Clinical and Diagnostic Laboratory Immunology, November 2004, p. 1194-1197, Vol. 11, No. 6
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.6.1194-1197.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.